Clinical Trial Update: Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients. [Phase 4]

View source ↗

Summary

This Phase 4 trial compares the efficacy and safety of Simdax (levosimendan) versus Dobutrex (dobutamine) in patients with decompensated heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Dobutrex (dobutamine)
• Simdax (levosimendan)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Heart Failure | Phase 4 | Status: COMPLETED